About N-of-One
N-of-One is a company based in Lexington (United States) founded in 2008 was acquired by Qiagen in January 2019.. N-of-One has raised $17.75 million across 6 funding rounds from investors including Philips, Qiagen and Excel Venture Management. N-of-One operates in a competitive market with competitors including Denali Therapeutics, Castle Biosciences, Juno Therapeutics, Atrys and Unity Biotechnology, among others.
- Headquarter Lexington, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of N-of-One
N-of-One has successfully raised a total of $17.75M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $7.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2017 | Amount | Series B - N-of-One | Valuation |
investors |
|
| Jul, 2016 | Amount | Series B - N-of-One | Valuation |
investors |
|
| Jan, 2016 | Amount | Series B - N-of-One | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in N-of-One
N-of-One has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Philips, Qiagen and Excel Venture Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early to late stage VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm
|
Founded Year | Domain | Location | |
|
Products and reagents for molecular diagnostic assays are supplied.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by N-of-One
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - N-of-One
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
N-Of-One Comparisons
Competitors of N-of-One
N-of-One operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Castle Biosciences, Juno Therapeutics, Atrys and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic and therapeutic services catering to cancer
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are provided through laboratories and radiology units.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on N-Of-One
Frequently Asked Questions about N-of-One
When was N-of-One founded?
N-of-One was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Where is N-of-One located?
N-of-One is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is N-of-One a funded company?
N-of-One is a funded company, having raised a total of $17.75M across 6 funding rounds to date. The company's 1st funding round was a Series B of $3M, raised on Aug 31, 2011.
What does N-of-One do?
N-of-One was founded in 2008 and is based in Lexington, United States. Operations focus on the healthcare sector, where tumor molecular profiles are interpreted to guide physicians in diagnostics and treatments. Services include Precision Insights for NGS panel reports and TrialMatch for matching patients to clinical trials based on molecular data. Decision support is provided to clinicians without functioning as a diagnostic lab or bioinformatics provider.
Who are the top competitors of N-of-One?
N-of-One's top competitors include Juno Therapeutics, Ambrx and Denali Therapeutics.
Who are N-of-One's investors?
N-of-One has 4 investors. Key investors include Philips, Qiagen, Excel Venture Management, and Allumia Ventures.